Livongo and Lilly Collaborate on Real-World Diabetes Research
The research collaboration will combine real-world behavioral studies and claims data to advance knowledge about effective interventions in diabetes care. The companies aim to contribute to medical literature in three areas:
- Measure the impact of remote diabetes self-management education and support on clinical and healthcare cost outcomes
- Understand drivers of healthy behaviors
- Understand how people living with diabetes can stay more actively involved in their health
Lilly has been a leader in diabetes care for more than 90 years, and was the first company to make insulin commercially available to people with the disease. Today, Lilly provides a wide range of therapies to address the diverse needs of people living with diabetes.
"Collaborating with Livongo is an important step in our research efforts," said
Livongo is redesigning chronic condition management, starting with diabetes. Livongo delivers a personalized experience, using data and clinical science, and helps to make staying healthy easier, which results in measurable positive health outcomes for people with diabetes1 and lower costs for payers2.
"These studies will have a direct impact on the lives of Livongo members," said
Livongo and Lilly aim to publish the results of their collaborative research studies to further advance diabetes care for people worldwide.
About Diabetes
Approximately 30 million Americans3 and an estimated 425 million adults worldwide have diabetes.4 More than one million children and adolescents have type 1 diabetes globally. 4 Type 2 diabetes is the most common type internationally, accounting for an estimated 90 to 95 percent of all diabetes cases in
About
Livongo has a vision of empowering all people with chronic conditions to live better and healthier lives. We are redesigning chronic condition management, starting with diabetes, by driving behavior change through the combination of consumer health technology, personalized recommendations, and real-time support at the point of impact. Powered by advanced analytics, we create personalized experiences for our members so they receive the right information, tools, and support, at the right time. Our approach is leading to better financial and clinical outcomes while creating a better experience for all people with chronic conditions and their care team of family, friends, and medical professionals. For more information visit: www.livongo.com.
About Lilly Diabetes
Lilly has been a global leader in diabetes care since 1923, when we introduced the world's first commercial insulin. Today we are building upon this heritage by working to meet the diverse needs of people with diabetes and those who care for them. Through research, collaboration and quality manufacturing we strive to make life better for people affected by diabetes. We offer a wide range of therapies and a continued determination to provide real solutions—from medicines and technologies to support programs and more. For the latest updates, visit www.lillydiabetes.com or follow us on Twitter: @LillyDiabetes and
About
Lilly is a global healthcare leader that unites caring with discovery to make life better for people around the world. We were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and today we remain true to that mission in all our work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism. To learn more about Lilly, please visit us at www.lilly.com and www.lilly.com/newsroom/social-channels.
This press release contains forward-looking statements (as that term is defined in the Private Securities Litigation Reform Act of 1995) about a strategic initiative between
P-LLY
01/2018
References
- Downing J, Bollyky J, Schneider J. Use of a Connected Glucose Meter and Certified Diabetes Educator Coaching to Decrease the Likelihood of Abnormal Blood Glucose Excursions: The Livongo for Diabetes Program. J Med Internet Res 2017;19(7):e234, DOI: 10.2196/jmir.6659
- Presentation at the 77th Annual
American Diabetes Association's Scientific Sessions. Centers for Disease Control and Prevention . National Diabetes Statistics Report, 2017. Available at: https://www.cdc.gov/diabetes/pdfs/data/statistics/national-diabetes-statistics-report.pdf.November 2017 .International Diabetes Federation . IDF Diabetes Atlas, 8th edn, 2017. Available at: http://www.diabetesatlas.org/.November 2017 .
Refer to:
View original content with multimedia:http://www.prnewswire.com/news-releases/livongo-and-lilly-collaborate-on-real-world-diabetes-research-300578410.html
SOURCE